Whitepapers
Application Highlight: A Highly Selective Method for the Analysis of Drospirenone in Human Plasma
Several common birth control formulations contain both drospirenone and ethinyl estradio. A highly selective and sensitive analytical method for the analysis of drospirenone in human plasma has been developed for use in bioequivalence studies.
JP Morgan Healthcare Conference
Alnylam RNAi Roundtable May 13, 2011 Agenda & Introductions Welcome Cynthia Clayton » Senior Director, Investor Relations and Corporate Communications Program Overview Akshay Vaishnaw, M.D., Ph.D. (Moderator) » Senior Vice President, Clinical Research Jared Gollob, M.D. » Senior Director, Clinical
Slide 1
ALN-VSP02 Phase 1 Trial Update Demonstrating RNAi in Man Jared A. Gollob, M.D. January 4, 2011 Dana-Farber Cancer Institute Agenda LNPs and ALN-VSP02: Background Phase 1 Trial Safety Data Pharmacodynamic Data » 5’ RACE » DCE-MRI Summary 2 Lipid Nanoparticles for Systemic Delivery 3 Liver Targeting
RNAi Therapeutics Targeting PCSK9 for LDLc Lowering in Hypercholesterolemia M. D. Frank-Kamenetsky1...
RNAi Therapeutics Targeting PCSK9 for LDLc Lowering in Hypercholesterolemia M. D. Frank-Kamenetsky1 , T. Racie1 , A. Akinc1 , N. Anderson2 , L. Nechev1 , S. Shulga-Morskaya1 , K. Mills1 , S. Millstein1 , T. Lei1 , R. Duncan1 , A. Grefhorst2 , G. Wang1 , R. Kallanthottathil1 , M. Maier1 , S. Semple3
Page:
